Improving the quality of life in pregnant women with gastroesophageal reflux disease as a marker of the effectiveness of the treatment
DOI:
https://doi.org/10.15574/PP.2025.2(102).712Keywords:
heartburn, regurgitation, pregnancy, quality of lifeAbstract
Aim - to investigate the effectiveness of the drug "Hialera" by determining the quality of life indicator in pregnant women with gastroesophageal reflux disease (GERD).
Materials and methods. The study included 30 pregnant women with GERD manifestations. Among them, 7 (23.3%) women had a confirmed diagnosis on fibrogastroscopy (FGDS) during this pregnancy, 6 (20.0%) women had a diagnosis of GERD confirmed before pregnancy during FGDS pregravidally. The remaining 17 (56.6%) pregnant women had heartburn and regurgitation, (and at night), during the period of 6-10 weeks during early toxicosis and after 30 weeks. Women answered of the GERD Health-Related Quality of Life (GERD-HRQL) questionnaire before and after treatment with Hyalera (1 stick 3-4 times a day as a plan or as needed when heartburn symptoms occurred). The survey results determined the impact of heartburn and regurgitation on a person's daily life and the effectiveness of treatment.
Results. Among the 30 pregnant women examined with clinical manifestations of GERD before the start of treatment, 25 (83.3%) patients noted heartburn/regurgitation daily; in 26 (86.6%) women the above symptoms affected daily activities. After 10 days of treatment, only 2 (6.6%) women had symptoms that persisted daily and 3 (10.0%) had symptoms that affected their daily activities. After treatment, 3 (10.0%) women reported feeling unwell compared to 26 (86.6%) pregnant women before treatment. After starting treatment, no women reported sleep disturbances related to heartburn.
Conclusions. A significant improvement in the quality of life was noted in pregnant women with heartburn after the start of treatment with the Hyalera remedy. It is important that the manifestations of heartburn and regurgitation decreased already during the first day after the start of treatment. It is also essential to restore a full night's sleep in pregnant women. The Hyalera remedy, due to its composition, helps eliminate heartburn and heaviness in the stomach, prevents the occurrence of repeated episodes of heartburn, reduces inflammation of the mucous membrane of the esophagus and stomach, normalizes the permeability of the mucous barrier of the esophagus and stomach
The study was carried out in accordance with the principles of the Declaration of Helsinki. The study protocol was approved by the Committee on bioethics and deontology of these institutions. The informed consent of the children's parents was obtained for the research.
No conflict of interests was declared by the authors.
References
Ali RAR, Hassan J, Egan LJ. (2022). Review of recent evidence on the management of heartburn in pregnant and breastfeeding women. BMC Gastroenterology. 22: 219. https://doi.org/10.1186/s12876-022-02287-w; PMid:35508989 PMCid:PMC9066781
Anderson PO. (2018). Treating gastroesophageal reflux and heartburn while breastfeeding. Breastfeed Med. 13(7): 463-464. https://doi.org/10.1089/bfm.2018.0124; PMid:30074826
Freedberg DE, Kim LS, Yang YX. (2017). The risks and benefits of long-term use of proton pump inhibitors: expert review and best practice advice from the American Gastroenterological Association. Gastroenterology. 152(4): 706-715. https://doi.org/10.1053/j.gastro.2017.01.031; PMid:28257716
Haraldstad K, Wahl A, Andenæs R, Andersen JR, Andersen MH, Beisland E et al. (2019). A systematic review of quality of life research in medicine and health sciences. Qual Life Res. 28(10): 2641-2650. https://doi.org/10.1007/s11136-019-02214-9; PMid:31187410 PMCid:PMC6761255
MacFarlane B. (2018). Management of gastroesophageal reflux disease in adults: a pharmacist's perspective. Integr Pharm Res Pract. 7: 41-52. https://doi.org/10.2147/IPRP.S142932; PMid:29892570 PMCid:PMC5993040
Mosiichuk L.M., Demeshkina L.V. (2022). Hastroezofahealna refliuksna khvoroba, poiednana z dysfunktsiieiu sfinktera Oddi: kontrol yakosti zhyttia patsiientiv. Hastroenterolohiia. 56; 2. https://doi.org/10.22141/2308-2097.56.2.2022.491
National Collaborating Centre for Women's and Children's Health. (2020, Apr). Antenatal care routine care for the healthy pregnant woman.
NICE. (2020, Apr 24). Antenatal care for uncomplicated pregnancies. URL: https://www.nice.org.uk/guidance/cg62/resources/antenatal care for uncomplicated pregnancies-pdf- 97556 45974 45.
Singh P, Salisbury BH, Terrell JM. (2020). Antacids. Treasure Island: StatPearls Publishing.
Strugala V, Bassin J, Swales VS, Lindow SW, Dettmar PW, Thomas E. (2012). Assessment of the safety and efficacy of a raft-forming alginate reflux suppressant (Liquid Gaviscon) for the treatment of heartburn during pregnancy. ISRN Obstet Gynecol. 2012: 481870. https://doi.org/10.5402/2012/481870; PMid:23209926 PMCid:PMC3503308
Thélin CS, Richter JE. (2020). The management of heartburn during pregnancy and lactation. Aliment Pharmacol Ther. 51(4): 421-434. https://doi.org/10.1111/apt.15611; PMid:31950535
WHOQOL - WHO. (2021, Sep 29). Measuring quality of life. URL: https://www.who.int/mental_health/media/68.pdf.
World Health Organization. (2020, May). WHO recommendation on interventions for the relief of heartburn during pregnancy.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Ukrainian Journal of Perinatology and Pediatrics

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The policy of the Journal “Ukrainian Journal of Perinatology and Pediatrics” is compatible with the vast majority of funders' of open access and self-archiving policies. The journal provides immediate open access route being convinced that everyone – not only scientists - can benefit from research results, and publishes articles exclusively under open access distribution, with a Creative Commons Attribution-Noncommercial 4.0 international license(СС BY-NC).
Authors transfer the copyright to the Journal “MODERN PEDIATRICS. UKRAINE” when the manuscript is accepted for publication. Authors declare that this manuscript has not been published nor is under simultaneous consideration for publication elsewhere. After publication, the articles become freely available on-line to the public.
Readers have the right to use, distribute, and reproduce articles in any medium, provided the articles and the journal are properly cited.
The use of published materials for commercial purposes is strongly prohibited.